LIFR and familial pancreatic carcinoma: Since there are robust evidence that the LIF/LIFR pathway exerts a pro-oncogenic role in PDAC cell lines (13, 20, 55), and because FXR expression is increased in human PDAC tissues, we have focused our attention on the role that natural and synthetic steroids exert in modulating pancreatic cancer cell lines.